Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

GSK-126

Inh 1346574-57-9 N-[(1,2-Dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-3-methyl-1-[(1S)-1-methylpropyl]-6-[6-(1-piperazinyl)-3-pyridinyl]-1H-indole-4-carboxamide
Produktnummer ABIN7233255

Kurzübersicht für GSK-126 (ABIN7233255)

Applikation

Inhibition (Inh)

Chemical Name

N-[(1,2-Dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-3-methyl-1-[(1S)-1-methylpropyl]-6-[6-(1-piperazinyl)-3-pyridinyl]-1H-indole-4-carboxamide
  • Verwendungszweck

    EZH2 Histone methyltransferase inhibitor

    Produktmerkmale

    Competitive, selective inhibitor of H3K27 methyltransferase EZH2 (Ki = 0.57 nM), over EZH1 (Ki = 89 nM) and other histone methyltransferases (Ki > 1 μM). GSK-126 caused a dose-dependent decrease in H3K27me3, and blocked invasion of triple-negative breast cancer cells. Conversely, it induced myeloid-derived suppressor cells, blocking antitumor immunity in mice. Decreases myeloma CSCs4, while also inducing differentiation of HepaRG hepatic progenitor cells5. Used to explore the role of epigenetic modification in a mouse model of Parkinson's disease.

    Reinheit

    >98 %

    Formel

    C31H38N6O2

    Löslichkeit

    Soluble in DMSO (up to 15 mg/ml) or in Ethanol (up to 2 mg/ml).
  • Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Powder

    Lagerung

    -20 °C
  • Hintergrund

    GSK-2816126,Cell migration,Epigenetics,Transcription,Protein methyltransferase,Stem cells,Cancer stem cells,Ubiquitin/Proteasome,Inflammation,Cancer,Neurodegeneration,Posttranslational modification,Pain,Chromatin

    Molekulargewicht

    526.7

    CAS-Nummer

    1346574-57-9
Sie sind hier:
Chat with us!